Friday, October 30, 2026

Kim Jong Un’s New Weapons Unproven, Analysts Say, Despite Leveraging U.S.-China Rivalry

North Korea's military modernization faces challenges in closing the gap with South Korea, despite new weapons developments.

GLP-1 Weight Loss Injections: Are They Causing Gallstone Surge in Asia?

GLP-1 obesity treatments are linked to increased gallstone risk, especially during rapid weight loss, with cases doubling in South Korea.

North Korea’s Nuclear Stance: Kim Jong Un’s Bold Conditions for U.S. Dialogue Revealed

Kim Jong Un signals openness to U.S. dialogue on nuclear status but rejects South Korea as an eternal enemy, complicating inter-Korean relations.

Future

How Celltrion’s Remsima SC is Revolutionizing IBD Treatment at UEG Week 2026

Celltrion showcases the competitiveness of its autoimmune treatment Remsima SC at Europe's largest gastroenterology conference.

Interview: Kim Kyo-heung Says South Korea Needs National Suicide Prevention Fund, Citing 240-to-1 Budget Gap With Traffic Safety

Democratic Party lawmaker Kim Kyo-heung is calling for a dedicated national suicide prevention fund, arguing that per-death spending on suicide prevention is just one-240th of traffic safety spending and urging coordinated support for vulnerable young people, including those facing isolation, addiction and mental health crises.

“Focus on What We Do Well”: Kim Yeol-hong’s Vision for Yoo Han Corp.’s Next 100 Years

Yoo Han Corp. R&D chief Kim Yeol-hong says the company’s next century should be built around repeatedly developing new drugs by deepening expertise in selected fields, adopting new technologies and attracting global talent.

Yoo Han Corp. R&D Chief Kim Yeol-hong: “We Expect a Second Lexraza This Year … and Will Expand Drug Development”

Yoo Han Corp. R&D chief Kim Yeol-hong said the company expects follow-up drug development results by year-end while continuing to build a broad pipeline through both internal research and external acquisitions.

Alteogen Strengthens Keytruda SC Exclusivity With European Composition Patent

Alteogen has secured a European composition patent for the subcutaneous formulation combining its ALT-B4 enzyme with Merck’s Keytruda, strengthening intellectual property protection for the product in Europe.
Latest

Interview: Vaim CEO Kim Geun-poong Looks to Patent Technology to Drive Juvelook’s Competitiveness

Vaim founder and manufacturing division CEO Kim Geun-poong says the company aims to build on Juvelook’s patented particle technology to develop a broader range of medical products and eventually expand into pharmaceuticals.

Boryung to Spin Off Sales and Marketing Business, Establishing 100%-Owned Subsidiary Boryung Pharma Solution

Boryung plans to separate its prescription-drug sales and marketing operations into a wholly owned subsidiary, Boryung Pharma Solution, as part of its strategy to build a specialized commercial platform.

8,000 Lung Cancer Experts to Gather in Seoul for International Conference After 19 Years

About 8,000 lung cancer experts will gather in Seoul for WCLC 2026, marking the city's first hosting of the international conference in 19 years.

AI, Digital Twins to Shape ‘Future Transit Centers’; U.S., Hong Kong Cases Shared

South Korea's Metropolitan Area Transport Commission will bring together domestic and overseas experts to explore future transit centers using AI and digital twin technologies, drawing on cases from the U.S. and Hong Kong.

Hyundai’s 5.8 Billion USD Louisiana Steel Plant: What It Means for the Future of EV Manufacturing

A large banner reading HYUNDAI-POSCO LOUISIANA STEEL welcomes visitors, with two cranes lifting high between them.

Experience the Magic: Highlights from the 2026 Seoul World Fireworks Festival

The Seoul World Fireworks Festival 2026 took place on September 5, featuring teams from Korea, the U.S., and the UK.

CJ ENM Launches K-Content FAST Channels on Amazon Prime Video: What to Expect?

CJ ENM expands collaboration with Amazon Prime Video to broaden the reach of K-content in the U.S. via FAST streaming services.

SCARLET PRO vs. SB-49TIP: Which FDA-Approved RF Device Will Transform Your Skincare Routine?

Viol Medical has received FDA 510(k) approval for its medical devices, SCARLET PRO and SB-49TIP, enhancing its market presence.

AI vs. Doctors: Who Should You Trust for Your Health Information?

Health inquiries have shifted from symptom searches online to more advanced methods of diagnosis and information access.

Techwing Secures 9.1 Billion KRW Semiconductor Equipment Deal with Micron India: What This Means for the Future

Techwing signs a supply contract worth 9.184 billion KRW with Micron's India unit, expanding its delivery regions after Malaysia.

LG CineBeam AI HU925V: The Ultimate 4K UHD Projector for Your Home Cinema

LG Electronics has launched the LG CineBeam AI (model HU925V), a premium ultra short throw projector after 4 years.

CJ Logistics Launches Humanoid Robots in Logistics: How AI is Transforming Warehousing in 2026

CJ Logistics accelerates automation in logistics by integrating humanoid robots into its operational processes, emphasizing physical AI.

Discover CJ CheilJedang’s New Hetbahn Soft Mini Rice: The Perfect 110g Solution for Dieters!

CJ CheilJedang introduces Hetbahn Soft Mini Rice, a 110g serving of premium white rice, on September 3.

OCI Energy and Arava Power Launch 260MW Solar Project in Texas: What You Need to Know

OCI Energy and Arava Power held a groundbreaking ceremony for the Sun Roper solar power plant in Israel.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.